MedPath

Febutor-40

Brand Name: Febutor-40

Generic Name: Febuxostat

Active
Registration Number

DR-XY48201

Dosage Form

Film-Coated Tablet

Issuance Date

July 20, 2022

Expiry Date

July 20, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength40 mg
PackagingAlu/Alu Blister Pack x 14's (Box of 14's and 28's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

FebuxostatActive
Monograph: Febuxostat

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.